RE:RE:So...BlueMetal75 wrote: skier59 wrote: They thought by announcing they have located the first subject for the Phase2 it would pump up the SP.......NOT. Probably another month before said subject patient gets treated at this rate.
Since the patient is already enrolled, I don't think it will take a month to treat. I would guess up to two weeks. So that would be this week or next week. And then the clock is finally ticking, for all the milestones in the study - 30 day, 90 day, and one year especially. About time!
I consider the part about dropping Europe to be very good news. It's bad enough dealing with two vast bureaucracies (HC and FDA), we don't need to add more. And streamlining the anticipated number of patients down to a total of 100 (in both countries) can only help, in terms of saving the company both time and money.
Like everyone else, I'm disgusted with the current share price...given the progress the company has made to date. But that aside, I don't see today's PR as anything but good news. I'll take it!
More, please!
I think they have also 7 days results included together with the 30, 90, 180 days, 270 days, 360 days results, so next Monday, we should get that results or instead get another patient treated news out. ..